When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Psoriatic arthritis - Wikipedia

   en.wikipedia.org/wiki/Psoriatic_arthritis

   Psoriatic arthritis (PsA) is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis. [1][2] The classic feature of psoriatic arthritis is swelling of entire fingers and toes with a sausage-like appearance ("sausage digit"). [3]

3. Apremilast - Wikipedia

   en.wikipedia.org/wiki/Apremilast

   Apremilast. Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4) and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells. [7]

4. Upadacitinib - Wikipedia

   en.wikipedia.org/wiki/Upadacitinib

   Upadacitinib, sold under the brand name Rinvoq, is a medication used for the treatment of rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and axial spondyloarthritis. [10][11] Upadacitinib is a Janus kinase (JAK) inhibitor that works by blocking the action of enzymes ...

5. This Is the Difference Between Rheumatoid and Psoriatic Arthritis

   www.aol.com/difference-between-rheumatoid...

   Psoriatic arthritis is a type of arthritis that develops in some people who have psoriasis, which is a chronic autoimmune disease of the skin. Psoriatic arthritis can be mild or severe. It can ...

6. Risankizumab - Wikipedia

   en.wikipedia.org/wiki/Risankizumab

   Risankizumab, sold under the brand name Skyrizi, is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, and Crohn's disease. [6][7] It is designed to target interleukin 23A (IL-23A). [6][7][9] It is given by subcutaneous injection. [6][7] The most common side effects include upper respiratory ...

7. Adalimumab - Wikipedia

   en.wikipedia.org/wiki/Adalimumab

   Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.